Información de la revista
Vol. 113. Núm. 1.
Páginas T91-T94 (Enero 2022)
Descargar PDF
Más opciones de artículo
Vol. 113. Núm. 1.
Páginas T91-T94 (Enero 2022)
Case and Research Letter
Open Access
[Translated article] Histopathology of Mycosis Fungoides in a Colombian Population: Towards the Characterization of South American Populations
Histopatología de micosis fungoide en una población colombiana. Identificando las características de la micosis fungoide en poblaciones suramericanas
M.N. Mejiaa,b, O.J. Valencia Ocampoa,b, L.A. Correaa,b, J.C. Wolffa, S. Correaa, M.M. Velásquez Loperaa,b,
Autor para correspondencia

Corresponding author.
a Sección Dermatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
b Centro de Investigaciones Dermatológicas CIDERM, Medellín, Colombia
Contenido relaccionado
M.N. Mejia, O.J. Valencia Ocampo, L.A. Correa, J.C. Wolff, S. Correa, M.M. Velásquez Lopera
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Descargar PDF
Figuras (1)
Tablas (1)
Table 1. Histopathological Findings According to Lesion Type: Patches and Macules, Plaques, and Tumors.
Texto completo
To the Editor:

Recognition of the typical histopathological findings of mycosis fungoides (MF) can help clinicians establish diagnosis and is of prognostic value for disease progression and treatment response. Although the histopathological characteristics of MF have been recorded since the earliest descriptions, peculiarities within the Colombian population have not been explored to date. Our objective was to describe the histopathology of MF in biopsy samples obtained at the Dermatopathology Laboratory of the University of Antioquia, Medellín, Colombia.

We reviewed all biopsy data collected at the Dermatopathology Laboratory of the University of Antioquia between March 1976 and January 2013. These results corresponded to clinical data and hematoxylin–eosin staining from 252 preselected confirmed diagnoses of cutaneous T-cell lymphoma, MF, parapsoriasis, and follicular mucinosis. Other lymphomas, Sézary syndrome, and post-treatment biopsies were excluded from our analysis. Of the selected samples, 90 corresponded to a diagnosis of MF. Data on HTLV 1 status were not available for any of the cases analyzed.

The median age (available in 87 of 90 cases) was 52 years, which is lower than that reported in the United States and Japan (58 and 55 y, respectively).1,2 Time to diagnosis was 3.8 years (range, 1 mo to 20 y), which is similar to that reported in recent studies. Strikingly, in 4 cases the reported clinical lesions were papules, and folliculotropism was described in only 1 case. Papules could be considered an initial lesion in the progression towards plaque formation. However, a clinical variant of papular MF has been described.3

The histopathological findings according to clinical lesion type are described in Table 1. Infiltrate was defined as follows: abundant, >50% infiltration of the dermoepidermal junction by atypical lymphocytes; moderate, 10–50% infiltration; scarce, <10% infiltration. Epidermotropism (evaluated at ×40 magnification) was defined as follows: abundant, >10 lymphocytes in the epidermis; moderate, 6–10 lymphocytes; scarce, 1–5 lymphocytes. Pautrier microabscesses were defined as the presence of at least 4 atypical lymphocytes in an intraepidermal vacuole. Papillary laminar fibrosis was defined as follows: grade 1, <10%; grade 2, 10–50%; and grade 3, >50%. These criteria were established by the group of dermatopathologists, given the absence of quantitative parameters in the literature.

Table 1.

Histopathological Findings According to Lesion Type: Patches and Macules, Plaques, and Tumors.

Finding, No. (%)  Severity  Patches, macules  Plaques  Tumors  Papules  Erythroderma 
    n = 23 (26.4%)  n = 37 (42.6%)  n = 14 (16.1%)  n = 4 (4.6%)  n = 9 (10.3%) 
Epidermal infiltrate, 87/87 (100)  Abundant infiltrate (23%)  30.40%  19%  28.50%  0%  22% 
  Moderate infiltrate (35.6%)  43.50%  40.50%  7.20%  50.00%  33.30% 
  Scarce infiltrate (41.4%)  26.10%  40.50%  64.30%  50.00%  44.40% 
Epidermotropism, 77/87 (88.5)  Abundant epidermotropism (10.4%)  13%  8%  7.10%  25%  0% 
  Moderate epidermotropism (20.8%)  17%  21.60%  14.30%  25%  11.10% 
  Scarce epidermotropism (68.8%)  56%  62%  57%  50%  77.80% 
Pautrier microabscesses    87%  59.50%  50%  50%  11.11% 
Basal vacuolization    87%  83.80%  64.30%  100%  55.60% 
Spongiosis    87%  81%  57.10%  100%  66.70% 
Papillary fibrosis    87%  75.70%  64.30%  75%  77.80% 
  Grade 1  78.30%  64.86%  35.70%  75%  77.80% 
  Grade 2  4%  10.80%  21.40%  0%  0.00% 
  Grade 3  4%  0.00%  7.00%  0%  0.00% 
Folliculotropic infiltrate    39%  40.50%  21.40%  25%  33.30% 
Syringotropic infiltrate    22%  29.73%  28.60%  25%  11.11% 
Follicular mucinosis    9%  16.22%  7.14%  25%  22.22% 
Follicular dilation and plugging    26%  27.00%  21.43%  25%  11.11% 
Follicular microabscesses    30%  27.00%  21.43%  25%  0.00% 
Neutrophils    4%  18.92%  7.14%  0%  0.00% 
Melanophages    44%  37.84%  35.71%  0%  22.22% 
Eosinophils    39%  24.32%  28.57%  0%  55.55% 
Erythrocytes    70%  48.65%  35.71%  50%  11.11% 
Perivascular infiltrate    65%  54.00%  35.71%  75%  33.33% 
Hemosiderin    9%  13.51%  0.00%  0%  0.00% 
Vascular ectasia    96%  78.40%  78.57%  25%  77.78% 
Necrotic keratinocytes    70%  56.76%  64.29%  100%  33.33% 

Epidermotropism has been considered a histopathological marker of MF and has been reported in more than 75% of cases.4 In our study it was detected in 90% of cases. Pautrier microabscesses were more frequent (61% of cases). Other authors have described this finding in 29%–37% of cases.5,6

Although MF has traditionally been described as the presence of epidermotropic lymphocytes in the absence of spongiosis,7 we frequently observed areas of vacuolization of the basal layer and spongiosis associated with or accompanied by lymphocyte marginalization. Marginalization and spongiosis were observed in 76% of cases (n = 68), and marginalization and vacuolization in 78% of cases (n = 70). Spongiosis and vacuolization of the basal cell layer have been described by other authors in up to 86% of cases.7 We do not consider these findings sufficient to rule out MF. The biological significance of these histological findings remains to be determined. It may also be useful to clinically evaluate patients for superimposed contact dermatitis and, in positive cases, to remove all stimuli that potentially contribute to increased inflammatory and tumoral activity.

Accompanying cells include eosinophils (reported in 12%–54% of cases) and plasma cells (4%–38% of cases).8,9 In our population we observed accompanying eosinophils and plasma cells in 31% and 29% of cases, respectively.

Folliculotropism was observed in 35% of the reviewed biopsies. The highest incidence reported in other series was in Norwegian patients (21%), although most authors report this finding in 10% of cases.10

Certain histopathological findings varied according to clinical lesion type. This was most notable for Pautrier microabscesses, which were present in 87% of patch- and plaque-type lesions, but in only 50% of tumors. Basal layer vacuolization and spongiosis were also more common in patches and plaques than in tumors (Fig. 1).

Figure 1.

A–C, Little reported but important findings. A, Extensive vacuolization of the basal layer (×10 magnification). B, Detail of vacuolization of the basal layer (×10). C, Vacuolization of the basal layer with effacement of the interface by atypical lymphocytes (×10). D–I, Other frequent findings. D, Vascular ectasia was observed in all stages of MF (×10). E, Dilation with corneal plugging of the infundibula (×10). F, Dilation with corneal plugging of the pores of the acrosyringia (×10). G, Extensive vacuolization of the basal layer (×10). H, Erythrocyte extravasation (×10). I, Spongiosis with microvesiculation associated with eosinophil exocytosis (×10), papules, and erythroderma.


In our population, in addition to the defining features of MF, we regularly observed foci of spongiosis and vacuolization of the basal layer, as well as folliculotropism. These findings may be related to the exposure of patients to exogenous agents that may participate in or exacerbate the immunopathogenic process in MF.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

V.D. Crisciones, M.A. Weinstock.
Incidence of cutaneous t-cell lymphoma in the United States, 1973-2002.
Arch Dermatol, 43 (2007), pp. 854-859
K. Yasukawa, N. Kato, K. Kodama, A. Hamasaka, H. Hata.
The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
J Cutan Pathol, 33 (2006), pp. 487-491
K. Kodama, R. Fink-Puches, C. Massone, H. Kerl, L. Cerroni.
Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
J Am Acad Dermatol, 52 (2005), pp. 694-698
B.J. Nickoloff.
Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides.
Am J Dermatopathol, 10 (1988), pp. 469-477
M. Santucci, A. Biggeri, A.C. Feller, D. Massi, G. Burg.
Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer.
Am J Surg Pathol, 24 (2000), pp. 40-50
P.R. Nielsen, J.O. Eriksen, U. Wehkamp, L.M. Lindahl, R. Gniadecki, H. Fogh, et al.
Clinical and histological characteristics of mycosis fungoides and Sézary syndrome: a retrospective single-centre study of 43 patients from Eastern Denmark.
Acta Derm Venereol, 99 (2019), pp. 1231-1236
H. Shamim, E.F. Johnson, L.E. Gibson, N. Comfere.
Mycosis fungoides with spongiosis: a potential diagnostic pitfall.
J Cutan Pathol, 46 (2019), pp. 645-652
Z.S. Naraghi, H. Seirafi, M. Valikhani, F. Farnaghi, S. Kavusi, Y. Dowlati.
Assessment of histologic criteria in the diagnosis of mycosis fungoides.
Int J Dermatol, 42 (2003), pp. 45-52
D.D. Apa, E.S. Pfeiffer, K. Baz, E.A. Kanik, P. Inandioğlu.
Histopathological changes seen in mycosis fungoides patients after phototherapy.
Am J Dermatopathol, 32 (2010), pp. 276-280
P. Mantaka, P. Helsing, P. Gjersvik, A. Bassarova, O.P.F. Clausen, J. Delabie.
Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series.
Acta Derm Venereol, 93 (2013), pp. 325-329

Please cite this article as: Mejia MN, Valencia Ocampo OJ, Correa LA, Wolff JC, Correa S, Velásquez Lopera MM. Histopatología de micosis fungoide en una población colombiana. Identificando las características de la micosis fungoide en poblaciones suramericanas. Actas Dermosifiliogr. 2022;113:91–94.

Copyright © 2021. AEDV
Actas Dermo-Sifiliográficas
Opciones de artículo
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?